Document Type

Article

Publication Date

2-12-2024

Comments

This article is the author’s final published version in Current Hepatology Reports, Volume 23, 2024, Pages 307–315.

The published version is available at https://doi.org/10.1007/s11901-024-00656-5. Copyright © The Author(s) 2024.

Publication made possible in part by support through a transformative agreement between Thomas Jefferson University and the publisher.

Abstract

Purpose of Review

This paper aims to investigate the crucial role of palliative care in the management of chronic liver disease (CLD) and cirrhosis. Faced with a global surge in liver-related morbidity and mortality, our goal is to understand the impact of early engagement with palliative care specialists on symptom management, quality of life, and the overall trajectory of advanced liver disease.

Recent Findings

While strides have been made in preventing and treating specific etiologies of CLD, such as viral infections, the escalating rates of alcohol use and obesity present new challenges for physicians. Despite advancements, liver transplantation unfortunately remains an elusive solution for many due to various constraints. Our review underscores the underutilization of palliative care in this context, emphasizing its potential to mitigate symptoms and enhance the overall well-being of patients and their caregivers.

Summary

Implementing palliative care early during CLD proves instrumental in reducing symptoms, hospitalizations, and resource utilization. This not only improves the quality of life for patients but also signifies a paradigm shift in approaching the uncertainties surrounding advanced liver disease. Urging further research and global initiatives, our findings advocate for a comprehensive integration of palliative care in the holistic management of patients with advanced liver disease.

Creative Commons License

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.

Language

English

Download

Share

COinS